Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05040152 · ClinicalTrials.gov registry record · NA
Weight Loss Intervention for the Reduction of Cancer Risk and Health Disparities in Rural Ohio
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05040152: Completed NA study, sponsored by Ohio State University Comprehensive Cancer Center.
NCT05040152 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05040152, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study determines the feasibility of a telephone-based weight lost intervention in reducing cancer risk and health disparities in rural Ohio. Obesity is the leading preventable cause of cancer, and obesity-related inflammation is linked to elevated cancer risk, independent of obesity itself. Rural populations are a vulnerable population in need of increased access to tailored strategies and benefit from weight loss interventions. This study aims to see whether a telephone-based intervention may help obese people in rural area to reduce body weight, so as to prevent obesity-related cancer.
Primary Outcome
Will be defined as the number of enrolled participants who complete the study.
Interventions
- OTHER Questionnaire Administration
- OTHER Exercise Intervention
- OTHER Informational Intervention
- BEHAVIORAL Telephone-Based Intervention
- BEHAVIORAL Dietary Counseling and Surveillance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-11-06 |
| Est. Completion | 2022-05-17 |
| Phase | NA |
What the finished NCT05040152 record still lists
NCT05040152 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 5 interventions - of which Questionnaire Administration is the first listed.
NCT05040152 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05040152 about?
NCT05040152 is a clinical study titled "Weight Loss Intervention for the Reduction of Cancer Risk and Health Disparities in Rural Ohio". This study determines the feasibility of a telephone-based weight lost intervention in reducing cancer risk and health disparities in rural Ohio. Obesity is the leading preventable cause of cancer, and obesity-related inflammation is linked to elevated cancer risk, independent of obesity itself. Rur...
What is the current status of trial NCT05040152?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2021-11-06. Estimated completion is 2022-05-17.
What interventions are being tested in trial NCT05040152?
The interventions under investigation include: Questionnaire Administration (OTHER), Exercise Intervention (OTHER), Informational Intervention (OTHER), Telephone-Based Intervention (BEHAVIORAL), Dietary Counseling and Surveillance (BEHAVIORAL).
Who is sponsoring clinical trial NCT05040152?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05040152's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI